Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00083161 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: etoposide

Sponsor

Gundersen Lutheran Health System